SoftMining applies its full-stack innovation pipeline to drug repurposing projects, leveraging advanced AI models, robotics, and patented technologies to identify new therapeutic uses for existing compounds. Our approach integrates in silico drug design with automated synthesis and validation, streamlining the process of repositioning drugs while reducing costs and accelerating timelines from discovery to proof-of-concept.